Bedeutung des Urokinasetyp-Plasminogenaktivators (uPA), des Plasminogenaktivator-Inhibitors 1 (PAI-1) und des Plasminogenaktivator-Inhibitors 2 (PAI-2) beim Mammakarzinom

Prognoseeinschätzung, Therapieoption des frühen Mammacarcinoms

Rights

Use and reproduction:

No license. The provisions of the German Copyright Act (UrhG) apply.

Please note that individual components of the publication may be subject to other licensing or copyright conditions.

Cite

Citation style:
Could not load citation form.